TUDCA Safety During Breastfeeding at 4 Months Postpartum
You can safely continue taking TUDCA while breastfeeding, as ursodeoxycholic acid (the parent compound of TUDCA) is considered safe during lactation with negligible transfer into breast milk.
Evidence Supporting Safety During Breastfeeding
The 2023 EASL guidelines provide the strongest recommendation for bile acid therapy during lactation. Ursodeoxycholic acid should be continued during breastfeeding as it is safe in pregnancy and lactation 1. This represents a strong recommendation with strong consensus from the European Association for the Study of the Liver 1.
The American Association for the Study of Liver Diseases similarly confirms that UDCA is safe in pregnancy and lactation 2. This guidance applies to women with primary biliary cholangitis, primary sclerosing cholangitis, and intrahepatic cholestasis of pregnancy 1.
Breast Milk Transfer Data
Research directly measuring bile acid concentrations in breast milk provides reassuring evidence:
- Total bile acid concentrations in breast milk of UDCA-treated patients were identical to untreated controls (3.2 ± 1 µmol/L vs. 3.2 ± 0.2 µmol/L) 3
- UDCA concentrations in breast milk remained negligible (0.69 µmol/L) and did not contribute meaningfully to the newborn bile acid pool 3
- No adverse effects were observed in breastfed infants whose mothers took UDCA, with normal postnatal development during 1-year follow-ups 3
Important Distinctions
While the evidence specifically addresses UDCA (ursodeoxycholic acid), TUDCA (tauroursodeoxycholic acid) is the taurine-conjugated form of the same bile acid. The safety profile should be comparable given their chemical similarity and shared mechanisms 1, 3.
Clinical Recommendations
Continue your TUDCA supplementation without concern for breastfeeding safety 1. The evidence demonstrates:
- Therapeutic bile acid administration during lactation poses no risk to breastfed infants 3
- The amount transferred into breast milk is clinically negligible 3
- No monitoring of the infant is required based on maternal UDCA/TUDCA use 3
Common Pitfalls to Avoid
Do not confuse TUDCA/UDCA with obeticholic acid, which should NOT be used during breastfeeding due to lack of safety data 1. UDCA and TUDCA have established safety profiles that obeticholic acid lacks 1.
If you are taking TUDCA for a diagnosed cholestatic liver condition and also using cholestyramine or other bile acid sequestrants, separate administration by at least 4 hours 1.